ANI PHARMACEUTICALS INC
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
ANIP$71.25+5.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income (Loss)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net Income (Loss) | $26,617 | $(24,166) | $50,847 | $(8,246) |
| Other comprehensive loss, net of tax: | ||||
| Foreign currency translation adjustment | 429 | (100) | 967 | (209) |
| Loss on interest rate swap | (930) | (2,862) | (3,500) | (3,282) |
| Total other comprehensive loss, net of tax | (501) | (2,962) | (2,533) | (3,491) |
| Total comprehensive income (loss), net of tax | $26,116 | $(27,128) | $48,314 | $(11,737) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.